Gubin receives cancer research grant

Matthew Gubin, PhD, postdoctoral research scholar in the laboratory of Robert Schreiber, PhD, Alumni Professor of Pathology and Immunology at Washington University School of Medicine in St. Louis, has received a three-year, $164,500 grant from the Cancer Research Institute for research titled “Using Genomics to Identify Targets of Checkpoint Blockade Cancer Treatment and Identify Optimal Target Antigens for Vaccination.”